Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 29
Filtrar
Más filtros

Banco de datos
País/Región como asunto
Tipo del documento
Intervalo de año de publicación
1.
Allergy ; 79(9): 2414-2422, 2024 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-38425088

RESUMEN

BACKGROUND: Increasing evidence is available about the presence of increased serum concentration of immunoglobulin (Ig) free light chains (FLCs) in both atopic and non-atopic inflammatory diseases, including severe asthma, providing a possible new biomarker of disease. METHODS: We analyzed clinical and laboratory data, including FLCs, obtained from a cohort of 79 asthmatic subjects, clinically classified into different GINA steps. A control group of 40 age-matched healthy donors (HD) was considered. Particularly, HD have been selected according to the absence of monoclonal components (in order to exclude paraproteinemias), were tested for total IgE (that were in the normal ranges) and were negative for aeroallergens specific IgE. Moreover, no abnormality of common inflammatory markers (i.e., erythrocyte sedimentation rate and C-reactive protein) was detectable. RESULTS: FLC-k levels were significantly increased in the asthmatic population, compared to the control group. Despite the absence of statistically significant differences in FLC-λ levels, the FLC-k/FLC-λ ratio displayed remarkable differences between the two groups. A positive correlation between FLC-κ and FLC-λ levels was found. FLC- λ level displayed a significant negative correlation with the FEV1 value. Moreover, the FLC-κ /FLC- λ ratio was negatively correlated with the SNOT-22 score and a positive correlation was observed between FLCs and Staphylococcus Aureus IgE enterotoxins sensitization. CONCLUSIONS: Our findings confirmed the role of FLCs in asthma as a potential biomarker in an inflammatory disease characterized by different endotypes and phenotypes. In particular, FLC-κ and FLC-k/FLC-λ ratio could be a qualitative indicator for asthma, while FLC-λ levels could be a quantitative indicator for clinical severity parameters.


Asunto(s)
Asma , Biomarcadores , Cadenas Ligeras de Inmunoglobulina , Índice de Severidad de la Enfermedad , Humanos , Asma/diagnóstico , Asma/inmunología , Asma/sangre , Biomarcadores/sangre , Masculino , Femenino , Persona de Mediana Edad , Cadenas Ligeras de Inmunoglobulina/sangre , Adulto , Anciano , Estudios de Casos y Controles , Inmunoglobulina E/sangre , Inmunoglobulina E/inmunología , Cadenas lambda de Inmunoglobulina/sangre
2.
J Investig Allergol Clin Immunol ; 34(1): 12-19, 2024 Feb 22.
Artículo en Inglés | MEDLINE | ID: mdl-37498647

RESUMEN

Plant species vary under different climatic conditions and the distribution of pollen in the air. Trends in pollen distribution can be used to assess the impact of climate change on public health. In 2015, the Mobile Airways Sentinel networK for rhinitis and asthma (MASK-air®) was launched as a project of the European Innovation Partnership on Active and Healthy Ageing (EIP-on-AHA, DG Santé and DG CONNECT). This project aimed to develop a warning system to inform patients about the onset of the pollen season, namely, the System for Integrated modeLling of Atmospheric coMposition (SILAM). A global-to-meso-scale dispersion model was developed by the Finnish Meteorological Institute (FMI). It provides quantitative information on atmospheric pollution of anthropogenic and natural origins, particularly on allergenic pollens. Impact of Air Pollution on Asthma and Rhinitis (POLLAR, EIT Health) has combined MASK-air clinical data with SILAM forecasts. A new Horizon Europe grant (Climate Action to Advance HeaLthY Societies in Europe [CATALYSE]; grant agreement number 101057131), which came into force in September 2022, aims to improve our understanding of climate change and help us find ways to counteractit. One objective of this project is to develop early warning systems and predictive models to improve the effectiveness of strategies for adapting to climate change. One of the warning systems is focused on allergic rhinitis (CATALYSE Task 3.2), with a collaboration between the FMI (Finland), Porto University (Portugal), MASK-air SAS (France), ISGlobal (Spain), Hertie School (Germany), and the University of Zurich (Switzerland). It is to be implemented with the support of the European Academy of Allergy and Clinical Immunology. This paper reports the planning of CATALYSE Task 3.2.


Asunto(s)
Asma , Rinitis Alérgica , Humanos , Alérgenos , Asma/epidemiología , Asma/etiología , Europa (Continente)/epidemiología , Catálisis
3.
Allergy ; 73(6): 1151-1181, 2018 06.
Artículo en Inglés | MEDLINE | ID: mdl-29105786

RESUMEN

To address uncertainties in the prevention and management of influenza in people with asthma, we performed a scoping review of the published literature on influenza burden; current vaccine recommendations; vaccination coverage; immunogenicity, efficacy, effectiveness, and safety of influenza vaccines; and the benefits of antiviral drugs in people with asthma. We found significant variation in the reported rates of influenza detection in individuals with acute asthma exacerbations making it unclear to what degree influenza causes exacerbations of underlying asthma. The strongest evidence of an association was seen in studies of children. Countries in the European Union currently recommend influenza vaccination of adults with asthma; however, coverage varied between regions. Coverage was lower among children with asthma. Limited data suggest that good seroprotection and seroconversion can be achieved in both children and adults with asthma and that vaccination confers a degree of protection against influenza illness and asthma-related morbidity to children with asthma. There were insufficient data to determine efficacy in adults. Overall, influenza vaccines appeared to be safe for people with asthma. We identify knowledge gaps and make recommendations on future research needs in relation to influenza in patients with asthma.


Asunto(s)
Asma/complicaciones , Asma/epidemiología , Gripe Humana/complicaciones , Gripe Humana/epidemiología , Gripe Humana/prevención & control , Antivirales/uso terapéutico , Costo de Enfermedad , Salud Global , Humanos , Inmunogenicidad Vacunal , Vacunas contra la Influenza/administración & dosificación , Vacunas contra la Influenza/efectos adversos , Vacunas contra la Influenza/inmunología , Gripe Humana/terapia , Evaluación del Resultado de la Atención al Paciente , Vigilancia en Salud Pública , Resultado del Tratamiento , Vacunación
4.
Allergy ; 72(2): 207-220, 2017 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-27775836

RESUMEN

It is well recognized that atopic sensitization is an important risk factor for asthma, both in adults and in children. However, the role of allergy in severe asthma is still under debate. The term 'Severe Asthma' encompasses a highly heterogeneous group of patients who require treatment on steps 4-5 of GINA guidelines to prevent their asthma from becoming 'uncontrolled', or whose disease remains 'uncontrolled' despite this therapy. Epidemiological studies on emergency room visits and hospital admissions for asthma suggest the important role of allergy in asthma exacerbations. In addition, allergic asthma in childhood is often associated with severe asthma in adulthood. A strong association exists between asthma exacerbations and respiratory viral infections, and interaction between viruses and allergy further increases the risk of asthma exacerbations. Furthermore, fungal allergy has been shown to play an important role in severe asthma. Other contributing factors include smoking, pollution and work-related exposures. The 'Allergy and Asthma Severity' EAACI Task Force examined the current evidence and produced this position document on the role of allergy in severe asthma.


Asunto(s)
Alérgenos/inmunología , Asma/diagnóstico , Asma/etiología , Hipersensibilidad/inmunología , Factores de Edad , Edad de Inicio , Animales , Asma/epidemiología , Diagnóstico Diferencial , Exposición a Riesgos Ambientales , Humanos , Hipersensibilidad/complicaciones , Hipersensibilidad/epidemiología , Hipersensibilidad/etiología , Hipersensibilidad Inmediata/complicaciones , Hipersensibilidad Inmediata/inmunología , Inmunoglobulina E/sangre , Inmunoglobulina E/inmunología , Exposición por Inhalación , Fenotipo , Índice de Severidad de la Enfermedad
5.
Allergy ; 71(4): 433-42, 2016 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-26505989

RESUMEN

Epidemiological research on the relationship between diet and asthma has increased in the last decade. Several components found in foods have been proposed to have a series of antioxidant, anti-allergic and anti-inflammatory properties, which can have a protective effect against asthma risk. Several literature reviews and critical appraisals have been published to summarize the existing evidence in this field. In the context of this EAACI Lifestyle and asthma Task Force, we summarize the evidence from existing systematic reviews on dietary intake and asthma, using the PRISMA guidelines. We therefore report the quality of eligible systematic reviews and summarize the results of those with an AMSTAR score ≥32. The GRADE approach is used to assess the overall quality of the existing evidence. This overview is centred on systematic reviews of nutritional components provided in the diet only, as a way to establish what type of advice can be given in clinical practice and to the general population on dietary habits and asthma.


Asunto(s)
Asma/epidemiología , Asma/etiología , Dieta , Factores de Edad , Asma/prevención & control , Suplementos Dietéticos , Frutas , Humanos , Oportunidad Relativa , Vigilancia de la Población , Riesgo , Vitamina D/administración & dosificación
6.
Allergy ; 70(10): 1212-21, 2015 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-26100553

RESUMEN

This document is the result of a consensus on the mechanisms of exercise-induced anaphylaxis (EIAn), an unpredictable and potentially fatal syndrome. A multidisciplinary panel of experts including exercise physiologists, allergists, lung physicians, paediatricians and a biostatistician reached the given consensus. Exercise-induced anaphylaxis (EIAn) describes a rare and potentially fatal syndrome in which anaphylaxis occurs in conjunction with exercise. The pathophysiological mechanisms underlying EIAn have not yet been elucidated although a number of hypotheses have been proposed. This review evaluates the validity of each of the popular theories in relation to exercise physiology and immunology. On the basis of this evidence, it is concluded that proposed mechanisms lack validity, and it is recommended that a global research network is developed with a common approach to the diagnosis and treatment of EIAn in order to gain sufficient power for scientific evaluation.


Asunto(s)
Anafilaxia/etiología , Ejercicio Físico , Anafilaxia/metabolismo , Anafilaxia/fisiopatología , Animales , Basófilos/inmunología , Basófilos/metabolismo , Tracto Gastrointestinal/irrigación sanguínea , Tracto Gastrointestinal/metabolismo , Hemodinámica , Liberación de Histamina , Humanos , Mastocitos/inmunología , Mastocitos/metabolismo , Concentración Osmolar , Permeabilidad , Flujo Sanguíneo Regional , Transglutaminasas/metabolismo
7.
Lupus ; 24(12): 1332-4, 2015 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-25966928

RESUMEN

Niemann-Pick disease is an inherited lipid storage disorder caused by the deficiency of acid sphingomyelinase, which results in accumulation of sphingomyelin within cells of several organs and consequent tissue damage. The broad clinical spectrum of this disorder may overlap with that of systemic lupus erythematosus, hindering differential diagnosis. Herein, we report the case of a patient affected by Niemann-Pick type B disease intertwined with clinical and serological features of systemic lupus erythematosus. Two novel mutations in the SMPD1 gene were found in compound heterozygosity: p.A36V and IVS2 + 8 T > G.


Asunto(s)
Lupus Eritematoso Sistémico/complicaciones , Enfermedades de Niemann-Pick/complicaciones , Esfingomielina Fosfodiesterasa/genética , Adulto , Femenino , Humanos , Mutación , Enfermedades de Niemann-Pick/genética , Fenotipo
9.
Allergy ; 68(4): 425-39, 2013 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-23452010

RESUMEN

BACKGROUND: Asthma and obesity are chronic multifactorial conditions that are associated with gene-environment interaction and immune function. Although the data are not fully consistent, it seems that obesity increases the risk of asthma and compromises asthma control. OBJECTIVE: To investigate the impact that weight changes have on asthma. METHODS: We carried out a systematic review of three large biomedical databases. Studies were scrutinized and critically appraised according to agreed exclusion and inclusion criteria. Quality assessment of eligible papers was conducted using the GRADE method. Meta-analyses of comparable studies were carried out. RESULTS: Thirty studies met the eligibility criteria of the review. Interventions were limited to dietary manipulation in three studies, one of which also used anti-obesity drugs, and bariatric surgery in four. All the other studies reported observational data. Becoming obese increased the odds for incident asthma by 1.82 (95% CI 1.47, 2.25) in adults and 1.98 (95% CI 0.71, 5.52) in children. Weight loss was associated with significant improvement in mean scores for symptoms, rescue medication score, and asthma exacerbations in the only randomized controlled trial. Similarly, evidence gathered from observational studies, with follow-up ranging between 8 weeks to 1 year, and from changes 1 year after bariatric surgery showed improvements in all asthma control-related outcomes. Changes in lung function were reported in one randomized controlled and eight observational studies of asthmatic subjects, with conflicting results. Either improvement after weight loss, decline with weight gain, or no effects at all were reported. Changes in airway inflammation and responsiveness were reported only by observational studies. CONCLUSION: Weight increases above the obesity threshold significantly increase the risk of asthma. The available studies show weak evidence of benefits from weight reduction on asthma outcomes.


Asunto(s)
Asma/etiología , Pérdida de Peso , Asma/epidemiología , Asma/fisiopatología , Medicina Basada en la Evidencia , Humanos , Incidencia , Obesidad/complicaciones
10.
Allergy ; 68(12): 1520-31, 2013 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-24410781

RESUMEN

Asthma exacerbations and severe asthma are linked with high morbidity, significant mortality and high treatment costs. Recurrent asthma exacerbations cause a decline in lung function and, in childhood, are linked to development of persistent asthma. This position paper, from the European Academy of Allergy and Clinical Immunology, highlights the shortcomings of current treatment guidelines for patients suffering from frequent asthma exacerbations and those with difficult-to-treat asthma and severe treatment-resistant asthma. It reviews current evidence that supports a call for increased awareness of (i) the seriousness of asthma exacerbations and (ii) the need for novel treatment strategies in specific forms of severe treatment-resistant asthma. There is strong evidence linking asthma exacerbations with viral airway infection and underlying deficiencies in innate immunity and evidence of a synergism between viral infection and allergic mechanisms in increasing risk of exacerbations. Nonadherence to prescribed medication has been identified as a common clinical problem amongst adults and children with difficult-to-control asthma. Appropriate diagnosis, assessment of adherence and other potentially modifiable factors (such as passive or active smoking, ongoing allergen exposure, psychosocial factors) have to be a priority in clinical assessment of all patients with difficult-to-control asthma. Further studies with improved designs and new diagnostic tools are needed to properly characterize (i) the pathophysiology and risk of asthma exacerbations, and (ii) the clinical and pathophysiological heterogeneity of severe asthma.


Asunto(s)
Asma/diagnóstico , Asma/terapia , Animales , Asma/prevención & control , Progresión de la Enfermedad , Humanos , Guías de Práctica Clínica como Asunto , Índice de Severidad de la Enfermedad
11.
Eur Rev Med Pharmacol Sci ; 27(16): 7868-7880, 2023 08.
Artículo en Inglés | MEDLINE | ID: mdl-37667964

RESUMEN

This review aimed to compare the different responses of countries to the pandemic, their National Health Systems, and their impact on citizens' health. This work aimed to create a narrative plot that connects different discussion points and suggests organizational solutions and strategic choices in the face of the pandemic. In particular, this work focused on public health organizations, specifically the European Union and vaccination politics. It is also based on a case report series (about the United States, Germany, Vietnam, New Zealand, Cuba, and Italy), where each country has responded differently to the pandemic in terms of political decisions such as vaccination type, information to citizens, dealings with independent experts, and other specific country factors. In comparing the various models of care systems response to the pandemic, it emerges that: we have found some (few) good practices, but without global coordination, and this is obviously not enough. It is now quite clear that there cannot be a "good answer" in a single nation. Uncoordinated local responses cannot counter a global phenomenon. The second point is that the general context must be considered from a strategic point of view. With the threat of new pandemics (but also of health disasters linked to climate change, pollution, and wars), humanity finds itself at the crossroads between investing in a "democratic" management of international bodies but without power (and at the mercy of the need for funds with consequent conflicts) or in some new leadership proposals that advocate efficiency and problem-solving (and that would probably be able to implement it) but that would place processes totally outside of the public's control.


Asunto(s)
COVID-19 , Desastres , Humanos , Pandemias/prevención & control , Investigación , Cambio Climático
12.
Pulmonology ; 2023 Aug 03.
Artículo en Inglés | MEDLINE | ID: mdl-37543524

RESUMEN

INTRODUCTION: Adherence to controller medication is a major problem in asthma management, being difficult to assess and tackle. mHealth apps can be used to assess adherence. We aimed to assess the adherence to inhaled corticosteroids+long-acting ß2-agonists (ICS+LABA) in users of the MASK-air® app, comparing the adherence to ICS+formoterol (ICS+F) with that to ICS+other LABA. MATERIALS AND METHODS: We analysed complete weeks of MASK-air® data (2015-2022; 27 countries) from patients with self-reported asthma and ICS+LABA use. We compared patients reporting ICS+F versus ICS+other LABA on adherence levels, symptoms and symptom-medication scores. We built regression models to assess whether adherence to ICS+LABA was associated with asthma control or short-acting beta-agonist (SABA) use. Sensitivity analyses were performed considering the weeks with no more than one missing day. RESULTS: In 2598 ICS+LABA users, 621 (23.9%) reported 4824 complete weeks and 866 (33.3%) reported weeks with at most one missing day. Higher adherence (use of medication ≥80% of weekly days) was observed for ICS+other LABA (75.1%) when compared to ICS+F (59.3%), despite both groups displaying similar asthma control and work productivity. The ICS+other LABA group was associated with more days of SABA use than the ICS+F group (median=71.4% versus 57.1% days). Each additional weekly day of ICS+F use was associated with a 4.1% less risk in weekly SABA use (95%CI=-6.5;-1.6%;p=0.001). For ICS+other LABA, the percentage was 8.2 (95%CI=-11.6;-5.0%;p<0.001). CONCLUSIONS: In asthma patients adherent to the MASK-air app, adherence to ICS+LABA was high. ICS+F users reported lower adherence but also a lower SABA use and a similar level of control.

13.
Allergy ; 67(4): 491-501, 2012 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-22257175

RESUMEN

Work-related asthma (WRA) is a relevant problem in several countries, is cause of disability and socioeconomic consequences for both the patient and the society and is probably still underdiagnosed. A correct diagnosis is extremely important to reduce or limit the consequences of the disease. This consensus document was prepared by a EAACI Task Force consisting of an expert panel of allergologists, pneumologists and occupational physicians from different European countries. This document is not intended to address in detail the full diagnostic work-up of WRA, nor to be a formal evidence-based guideline. It is written to provide an operative protocol to allergologists and physicians dealing with asthma useful for identifying the subjects suspected of having WRA to address them to in-depth investigations in a specialized centre. No evidence-based system could be used because of the low grade of evidence of published studies in this area, and instead, 'key messages' or 'suggestions' are provided based on consensus of the expert panel members.


Asunto(s)
Asma Ocupacional/diagnóstico , Comités Consultivos , Europa (Continente) , Humanos , Pruebas de Función Respiratoria
14.
Int J Immunopathol Pharmacol ; 25(1): 269-73, 2012.
Artículo en Inglés | MEDLINE | ID: mdl-22507340

RESUMEN

Icatibant, an antagonist of the bradykinin B2 receptor, was approved for the treatment of acute attacks of hereditary angioedema in the EU in 2008. This paper presents the case of a 65-year-old woman affected by frequent acute attacks of hereditary angioedema who benefitted from a change of therapy to icatibant, following years of treatment with C1-inhibitor.


Asunto(s)
Angioedemas Hereditarios/tratamiento farmacológico , Antagonistas del Receptor de Bradiquinina B2 , Bradiquinina/análogos & derivados , Anciano , Bradiquinina/uso terapéutico , Proteína Inhibidora del Complemento C1/análisis , Proteína Inhibidora del Complemento C1/uso terapéutico , Femenino , Humanos
15.
J Biol Regul Homeost Agents ; 26(4): 785-8, 2012.
Artículo en Inglés | MEDLINE | ID: mdl-23241130

RESUMEN

Autoimmune complications in the context of primary immunodeficiency diseases represent a well-known phenomenon, and this is widely recognized also for Selective Immunoglobulin A deficiency (IgAD), the most common primary antibody deficiency (PAD). Relapsing polychondritis (RP) is a rare immune-mediated, difficult to treat, disorder in which the cartilaginous tissues are the target for inflammation and damage. Ocular inflammatory manifestations in RP are frequent and often sight-threatening. Antiphospholipid syndrome (APS) is an acquired prothrombotic state related to circulating autoantibodies against phospholipids and/or their cofactors. Rare reports of APS associated to RP, PAD and APS or PAD and RP are available.


Asunto(s)
Anticuerpos Monoclonales/uso terapéutico , Síndrome Antifosfolípido/complicaciones , Deficiencia de IgA/complicaciones , Policondritis Recurrente/tratamiento farmacológico , Factor de Necrosis Tumoral alfa/antagonistas & inhibidores , Femenino , Humanos , Infliximab , Persona de Mediana Edad
16.
West Indian Med J ; 59(3): 287-90, 2010 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-21291108

RESUMEN

OBJECTIVE: The aim of this study is to evaluate the usefulness of Free Running Asthma Screening Test (FRAST) as a method that may help the diagnosis of exercise-induced bronchospasm (EIB) in children from a rural area and to compare the results with their history of asthma. METHODS: A FRAST challenge took place at 9 schools. It lasted for 6 minutes and pupils performed it properly with the help of an athlete. The best out of three Peak Expiratory Flow Rate (PEFR) efforts was recorded before and after challenge, using a mini-Wright peak-flow-meter. A more than 15% drop in PEFR was considered an indication of EIB. A questionnaire defining asthmatic symptoms had been distributed and already completed by their parents. RESULTS: The exercise was successfully performed by 268 children. Eleven children presented a fall of PEFR of at least 15%, five or ten minutes after the exercise; among these, only three boys had a history of asthma, while the remaining 8 children were undiagnosed. No difference regarding age, gender or locations' altitude was found. CONCLUSION: FRAST can be of great use in the diagnosis of EIB in areas that lack proper tools and specialized personnel. A poor correlation between self-reported symptoms and the results of exercise challenges was confirmed.


Asunto(s)
Asma Inducida por Ejercicio/diagnóstico , Niño , Prueba de Esfuerzo , Femenino , Humanos , Masculino , Tamizaje Masivo , Encuestas y Cuestionarios
17.
Allergy ; 63(4): 387-403, 2008 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-18315727

RESUMEN

AIMS: To analyze the changes in the prevalence of asthma, bronchial hyperresponsiveness (BHR) and allergies in elite athletes over the past years, to review the specific pathogenetic features of these conditions and to make recommendations for their diagnosis. METHODS: The Task Force reviewed present literature by searching Medline up to November 2006 for relevant papers by the search words: asthma, bronchial responsiveness, EIB, athletes and sports. Sign criteria were used to assess level of evidence and grades of recommendation. RESULTS: The problems of sports-related asthma and allergy are outlined. Epidemiological evidence for an increased prevalence of asthma and BHR among competitive athletes, especially in endurance sports, is provided. The mechanisms for development of asthma and bronchial hyperresponsiveness in athletes are outlined. Criteria are given for the diagnosis of asthma and exercise induced asthma in the athlete. CONCLUSIONS: The prevalence of asthma and bronchial hyperresponsiveness is markedly increased in athletes, especially within endurance sports. Environmental factors often contribute. Recommendations for the diagnosis of asthma in athletes are outlined.


Asunto(s)
Asma Inducida por Ejercicio , Hiperreactividad Bronquial , Hipersensibilidad , Medicina Deportiva , Comités Consultivos , Animales , Asma Inducida por Ejercicio/diagnóstico , Asma Inducida por Ejercicio/epidemiología , Asma Inducida por Ejercicio/etiología , Asma Inducida por Ejercicio/fisiopatología , Hiperreactividad Bronquial/diagnóstico , Hiperreactividad Bronquial/epidemiología , Hiperreactividad Bronquial/etiología , Hiperreactividad Bronquial/fisiopatología , Diagnóstico Diferencial , Humanos , Hipersensibilidad/epidemiología , Hipersensibilidad/etiología , Prevalencia , Sociedades Médicas
18.
Allergy ; 63(5): 492-505, 2008 May.
Artículo en Inglés | MEDLINE | ID: mdl-18394123

RESUMEN

AIM: The aims of part II is to review the current recommended treatment of exercise-induced asthma (EIA), respiratory and allergic disorders in sports, to review the evidence on possible improvement of performance in sports by asthma drugs and to make recommendations for their treatment. METHODS: The literature cited with respect to the treatment of exercise induced asthma in athletes (and in asthma patients) is mainly based upon the systematic review given by Larsson et al. (Larsson K, Carlsen KH, Bonini S. Anti-asthmatic drugs: treatment of athletes and exercise-induced bronchoconstriction. In: Carlsen KH, Delgado L, Del Giacco S, editors. Diagnosis, prevention and treatment of exercise-related asthma, respiratory and allergic disorders in sports. Sheffield, UK: European Respiratory Journals Ltd, 2005:73-88) during the work of the Task Force. To assess the evidence of the literature regarding use of beta(2)-agonists related to athletic performance, the Task Force searched Medline for relevant papers up to November 2006 using the present search words: asthma, bronchial responsiveness, exercise-induced bronchoconstriction, athletes, sports, performance and beta(2)-agonists. Evidence level and grades of recommendation were assessed according to Sign criteria. RESULTS: Treatment recommendations for EIA and bronchial hyper-responsiveness in athletes are set forth with special reference to controller and reliever medications. Evidence for lack of improvement of exercise performance by inhaled beta(2)-agonists in healthy athletes serves as a basis for permitting their use. There is a lack of evidence of treatment effects of asthma drugs on EIA and bronchial hyper-responsiveness in athletes whereas extensive documentation exists in treatment of EIA in patients with asthma. The documentation on lack of improvement on performance by common asthma drugs as inhaled beta(2)-agonists with relationship to sports in healthy individuals is of high evidence, level (1+). CONCLUSIONS: Exercise induced asthma should be treated in athletes along same principles as in ordinary asthma patients with relevance to controller and reliever treatment after careful diagnosis. There is very high level of evidence for the lack of improvement in athletic performance by inhaled beta2-agonists.


Asunto(s)
Asma Inducida por Ejercicio/tratamiento farmacológico , Hiperreactividad Bronquial/tratamiento farmacológico , Doping en los Deportes , Hipersensibilidad/tratamiento farmacológico , Administración por Inhalación , Agonistas Adrenérgicos beta/uso terapéutico , Comités Consultivos , Antiasmáticos/uso terapéutico , Asma Inducida por Ejercicio/epidemiología , Asma Inducida por Ejercicio/fisiopatología , Hiperreactividad Bronquial/epidemiología , Hiperreactividad Bronquial/fisiopatología , Directrices para la Planificación en Salud , Humanos , Hipersensibilidad/epidemiología , Hipersensibilidad/fisiopatología , Ensayos Clínicos Controlados Aleatorios como Asunto , Sociedades Médicas , Medicina Deportiva
19.
Allergy ; 63(8): 953-61, 2008 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-18691297

RESUMEN

Exercise-induced (EI) hypersensitivity disorders are significant problems for both recreational and competitive athletes. These include EI-asthma, EI-bronchoconstriction, EI-rhinitis, EI-anaphylaxis and EI-urticaria. A group of experts from the European Academy of Allergology and Clinical Immunology and the American Academy of Allergy Asthma and Immunology met to discuss the pathogenesis of these disorders and how to diagnose and treat them, and then to develop a consensus report. Key words (exercise with asthma, bronchoconstriction, rhinitis, urticaria or anaphylaxis) were used to search Medline, the Cochrane database and related websites through February 2008 to obtain pertinent information which, along with personal reference databases and institutional experience with these disorders, were used to develop this report. The goal is to provide physicians with guidance in the diagnosis, understanding and management of EI-hypersensitivity disorders to enable their patients to safely return to exercise-related activities.


Asunto(s)
Ejercicio Físico , Hipersensibilidad/etiología , Anafilaxia/etiología , Asma Inducida por Ejercicio/etiología , Humanos , Hipersensibilidad/diagnóstico , Hipersensibilidad/terapia , Rinitis/etiología , Síndrome , Urticaria/etiología
20.
Tumori ; 72(4): 365-74, 1986 Aug 31.
Artículo en Inglés | MEDLINE | ID: mdl-3490026

RESUMEN

We report a case of classical Kaposi's sarcoma (KS) in a patient affected by B-cell chronic lymphocytic leukemia for 2 years and who had not received any antiblastic treatment. At the ultrastructural analysis the leukemic cell showed rather immature features, and the immunologic phenotype (absence of detectable cytoplasmic Ig, and expression only of the DR, B2 and IgD lambda molecules on the surface membrane) proved its intermediate level of maturity, its monoclonality and relative rarity. The patient presented a complex immunologic deficiency, revealed not only by the monoclonality of the B lymphocytes and their low degree of maturity, but also by the almost total absence of T helper lymphocytes, by the high reduction in NK activity, by the very scarce proliferative response to the polyclonal mitogens PHA, ConA and PWM, and by a complete anergy to the skin test of delayed reactivity. The search for antibodies against the viruses EBV, CMV, HTLV-I and HTLV-III in the serum was negative. At the HLA typing, the patient was DR5, as are most classical KS and/or B-CLL patients. The data are discussed in relation to documented non-casual association between B-CLL and KS. We stress that immunosuppression may play an important role in the pathogenesis of both diseases and the possibility of their being conditioned by common genetic HLA-associated factors of predisposition.


Asunto(s)
Leucemia Linfoide/complicaciones , Sarcoma de Kaposi/etiología , Sarcoma de Kaposi/inmunología , Anciano , Linfocitos B , Antígenos HLA-DR/análisis , Humanos , Leucemia Linfoide/inmunología , Leucemia Linfoide/patología , Masculino , Fenotipo , Sarcoma de Kaposi/patología , Linfocitos T/inmunología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA